The SCN5A gene encodes a voltage-sensitive sodium channel expressed in cardiac and skeletal muscle. Coding region mutations cause cardiac sudden death syndromes and conduction system failure. Polymorphisms in the 5-sequence adjacent to the SCN5A gene have been linked to cardiac arrhythmias. We identified three alternative 5-splice variants (1A, 1B, and 1C) of the untranslated exon 1 and two 3-variants in the murine Scn5a mRNA. Two of the exon 1 isoforms (1B and 1C) were novel when compared with the published human and rat SCN5A sequences. Quantitative real time PCR results showed that the abundance of the isoforms varied during cardiac development. The 1A, 1B, and 1C mRNA splice variants increased 7.8 ؎ 1.7-fold (E1A), 6.0 ؎ 1.0-fold (E1B), and 20.6 ؎ 3.7-fold (E1C) from fetal to adult heart, respectively. Promoter deletion and luciferase reporter gene analysis using cardiac and skeletal muscle cell lines demonstrated a pattern of distinct cardiac-specific enhancer elements associated with exons 1A and 1C. In the case of exon 1C, the enhancer element appeared to be within the exon. A 5-repressor preceded each cardiac enhancer element. We concluded that the murine Na ؉ channel has both 5-and 3-untranslated region mRNA variants that are developmentally regulated and that the promoter region contains two distinct cardiac-specific enhancer regions. The presence of homologous human splicing suggests that that these regions may be fruitful new areas of study in understanding cardiac sodium channel regulation and the genetic susceptibility to sudden death.
The voltage-sensitive sodium channel (Na v 1.5) ␣-subunit is encoded by the SCN5A gene, and its product is the main determinant of Na ϩ influx and excitability in cardiac cells. In humans, mutations of the coding region cause sudden death syndromes such as long QT type 3 (1), idiopathic ventricular fibrillation (2-7), and progressive cardiac conduction defect (8, 9) . Recent reports indicated that polymorphisms of sequences 5Ј to the human SCN5A gene might contribute to cardiac arrhythmias in the general population (10) .
The Na v 1.5 sodium channel is prominently expressed in heart but has been detected also in prenatal skeletal muscle (11) and jejunal circular smooth muscle (12) . All or parts of the cardiac SCN5A gene have been cloned from several species, including humans, rats, mice, cows, dogs, and guinea pigs. Each of these genes shows a high degree of homology. For example, between humans, rats, and mice, coding region homology is as high as 99%, and genomic structure is maintained in all species for which the sequences are known.
Cardiac sodium channel dysfunction as the result of coding region mutations has been well described. Mutations can result in changes of the gating kinetics of the channel, expression level, and distribution pattern on the cell membrane (12, 13) . On the other hand, little is known about the transcriptional and translational regulation of SCN5A that seem to be important determinants of channel expression. One report suggesting the importance of this type of regulation showed that antiarrhythmic drugs could up-regulate cardiac Na ϩ channel mRNA and subsequent current expression (14) . Moreover, heart failure and atrial fibrillation have been shown to reduce Na ϩ channel mRNA abundance (15, 16) , and this may have a role in the pathophysiology of these conditions.
The promoter regions of a few voltage-gated Na ϩ channels have been studied. These include the brain sodium channel II (SCN2A) (17, 18) and one type of skeletal muscle sodium channel (rSkM2) (19, 20) . Recently, Yang et al. (10) have described multiple transcription initiation sites in human SCN5A, but little else is known about the promoter region of this important channel. To investigate the regulatory elements of the Scn5a gene, we have isolated and characterized mouse genomic clones encoding the cardiac sodium channel. We identified multiple novel transcription start sites associated with three untranslated exon 1 splice variants. Also, we have identified two 3Ј-splice variants. The mRNA abundance of these splice variants was developmentally regulated. Promoter analysis revealed that there were two regions containing cardiac-specific elements. Each promoter region was preceded by repressor elements. Thus, the Scn5a gene showed a complex transcriptional regulation and the possibility of six mRNA variants, giving the opportunity of translational control. Transcriptional or translational alterations might contribute to variations in Na ϩ channel current and the risk for arrhythmia.
EXPERIMENTAL PROCEDURES

Cloning of the Mouse Scn5a
Gene-PCR primers RHI28F/R (Table I) were used to screen Down-To-The-Well 129sv/J mouse embryonic stem cell bacterial artificial chromosome (BAC) 1 DNA pools (Genome Systems, St. Louis, MO). The primers were designed based upon the re-* This work was supported by National Institutes of Health Grant HL64828, a Department of Veterans Affairs Merit grant, and an American Heart Association Established Investigator Award. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ported rat cardiac sodium channel gene exon 28 cDNA sequence (GenBank TM accession number M27902). Two positive BAC clones on vector pBeloBAC11, GS 24810 and 24811, were found to contain Scn5a sequences. Sequencing the ends of BAC clone 24810 confirmed that this BAC contained a fragment of mouse chromosome 9. Subsequent sequencing of the entire region containing the Scn5a gene was carried out with a series of primers.
Characterization of the 5Ј-and 3Ј-Ends of Scn5a
Transcript by Rapid Amplification of cDNA Ends-Heart tissue from CD1 adult and 16-day postcoitum embryos was homogenized, and total RNA was isolated using the RNeasy minikit following the manufacturer's instructions (Qiagen, Valencia, CA). RNA ligase-mediated rapid amplification of cDNA ends (RACE) methods were used to characterize the 5Ј-and 3Ј-ends of the mouse Scn5a mRNA using a GeneRacer kit (Invitrogen). Briefly, 1 g of total RNA was treated with calf intestinal phosphatase to remove the 5Ј-phosphates of the truncated mRNA and non-mRNA forms of total RNA. Tobacco acid pyrophosphatase was used to remove the 5Ј-cap structure from intact full-length mRNA, and T4 RNA ligase was used to add the GeneRacer RNA oligo to the 5Ј-end of the mRNA. The first strand cDNA was synthesized by SuperScript II reverse transcription using a reverse gene-specific primer GSP5Ј (Table I) complementary to exon 3 of the mouse Scn5a gene and the GeneRacer oligo(dT) primer at the 5Ј-and 3Ј-ends, respectively. The 5Ј-and 3Ј-end PCR reactions were performed with platinum Pfx DNA polymerase using 10 M GSP5Ј and the GeneRacer 5Ј-primer for amplifying the 5Ј-end fragment and using 10 M the forward GSP3Ј (Table I) complementary to exon 28 of the mouse Scn5a and the GeneRacer oligo(dT) primer to obtain the 3Ј-end. An additional PCR reaction with nested primers was performed. The nested PCR products were cloned into pCRII-TOPO vector (Invitrogen) and sequenced to confirm that the RACE-PCR products were from the Scn5a cDNA. For the 3Ј-untranslated region (UTR) splice variants, relative mRNA variant abundance was analyzed by gel densitometry of the PCR results using the ImageQuant software (Amersham Biosciences) and normalized to the abundance of ␤-actin.
Primary DNA sequence analysis was performed with the Vector NTI 6 software (Informax, Frederick, MD). The sequences were aligned to mouse genomic DNA and cDNA sequences in the GenBank TM data base to identify transcription start sites (TSSs) and 3Ј-poly(A) sites. The presumptive promoter region was screened for CpG islands using the CPG-PLOT program and for transcription biding sites by using TFSEARCH.
RT-PCR Assay for Quantification of Scn5a Transcripts-To determine the abundance of different cardiac cDNAs carrying variant exon 1 isoforms, total RNA from adult mice and 16-day postcoitum embryos were isolated using the RNeasy minikit with the addition of RNase-free DNase I. Reverse transcription was carried out at 37°C for 1 h with Omniscript reverse transcriptase (Qiagen), 1 g of total RNA, and 10 M random hexamers (Roche Applied Science). The first strand cDNA was used as a template for subsequent PCR. Each PCR reaction contained 12.5 l of QuantiTect SYBR green PCR kit master mix (Qiagen) and 2.5 M primer pairs in a total 25-l reaction volume. The forward primers for exon 1 variants were E1AF (exon 1A), E1BF (exon 1B), and E1CF (exon 1C), respectively ( Table I ). The reverse primer rtpcr/R (Table I) was constant in each case. The reactions gave rise to 158-, 104-, and 103-bp PCR products, respectively. All amplifications were performed in triplicate and consisted of 50 cycles of 30 s at 94°C, 30 s at 60°C, and 1 min at 72°C in a Bio-Rad (Hercules, CA) thermocycler iCycler. PCR products were analyzed by electrophoresis on 1.5% agarose gels. ␤-Actin was used as a reference when making quantitative comparisons.
Promoter-Reporter Constructs-Because of the total length of the region (Ͼ15 kb), two contiguous Scn5a promoter regions were amplified separately by PCR using the primer pairs EPF/EPR and APF-KpnI/ APR-BglII (Table I) using TaqPlus Maxx DNA polymerase (Stratagene, La Jolla, CA) to obtain GC-rich PCR products with high sensitivity and fidelity. BAC clone 24810 was used as a template. The primers EPF/ EPR produced a 3.4-kb amplicon referred to as promoter A (Pa). A SacII-KpnI digest representing nearly the entire Pa amplicon was cloned into pCR-XL-TOPO (Invitrogen) and subsequently subcloned into the KpnI-SacI sites of the pGL3-basic vector designated as pGL3-PaKSI containing the fragment from Ϫ18.71 to Ϫ15.53 kb of the Scn5a gene (the first base pair of the start codon is referred to as ϩ1). A series of restriction enzyme digestions with KpnI combined with BstEII, NsiI, AscI, and PstI and blunt ligation after pretreatment by mung bean nuclease (New England Biolabs, Beverly, MA) created the different promoter A reporter constructs, pGL3-PaBSI (Ϫ17.81 to Ϫ15.53 kb), pGL3-PaNSI (Ϫ16.96 to Ϫ15.53 kb), pGL3-ASI (Ϫ16.50 to Ϫ15.53 kb), and pGL3-PaPSI (Ϫ16.16 to Ϫ15.53 kb), respectively, and digestion with AscI and SacI and blunt end ligation after mung bean nuclease digest created a promoter A fragment from Ϫ16.50 to Ϫ15.93 kb referred to as pGL3-PaKA.
The primer pair APF-KpnI/APR-BglII (Table I ) generated a 3.0-kb DNA fragment referred as to promoter B (Pb) containing Ϫ2161 to Ϫ24 bp upstream of ATG. This fragment was cloned into the KpnI-BglII sites of the luciferase reporter plasmid, pGL3-basic (Promega, Madison, WI) and was named pGL3-Pb3.0KB. The primer pairs AHE1F/APR (Ϫ855 to Ϫ24 bp) and AHI1F/APR (from intron Ϫ664 to Ϫ24 bp) were used to amplify Pb0.8 (containing exon 1C) and Pb0.6 (not containing exon 1C), respectively. The PCR products were cloned into pCR-XL-TOPO and subcloned into pGL3-basic at the KpnI and XhoI sites.
Cell Culture and Transient Transfection-The rat embryonic cardiomyocyte cell line H9c2 (ATCC catalog number CRL-1446) and the murine skeletal myoblast cell line C2C12 (gift from Dr. Roy Sutliff) were cultured in Dulbecco's modified Eagle's medium (Invitrogen) with 10% fetal calf serum under standard tissue culture conditions at 37°C. Cells were trypsinized at 70 -80% confluence, and 2.5 ϫ 10 5 cells were plated in each well of 6-well plates and allowed to attach overnight. Transfection of 3.0 g of each promoter-reporter construct and 0.1 g of the Rous sarcoma virus-driven ␤-galactosidase-expressing plasmid (RSV␤-gal, Promega, Madison, WI) was carried out with 10 l of Polyfect or Superfect chemical transfection reagents (Qiagen) following the manufacturer's instructions. After culture in Dulbecco's modified Eagle's medium for 48 h, the cells were treated with lysis buffer (Promega, Madison, WI), and cell extracts were collected for analysis of luciferase and ␤-galactosidase activity using 100 l of luciferase assay substrate (Promega, Madison, WI) and 100 l of Galacto-Star substrate (Applied Biosystems, Bedford, MA). Light emission was quantified in an automated luminometer using PlateReader 3.0 software (Packard Instrument Co.). The constructs pGL3-control (promoter and enhancer) and pGL3-basic (promoterless) were used in all transfection experiments as positive and negative controls, respectively. Transfection efficiency of the reporter constructs was controlled by comparison to ␤-galactosidase activity. The luciferase activity of all of the promoter constructs was normalized to a pGL3-basic promoterless control. At least three separate transfection sessions were employed, and at each session, transfections were performed in triplicate. Three luciferase/␤-galactosidase readings were taken for each transfection experiment. All data are presented as means Ϯ S.E. Statistical analysis of mean values was carried out using Student's paired or unpaired t tests.
RESULTS
Isolation of Mouse Cardiac Scn5a Genomic Clones-PCR
screening of the mouse BAC library for exon 28 of Scn5a identified two genomic BAC clones containing mouse cardiac sodium channel sequences. Southern blotting and sequencing confirmed the presence of Scn5a. BAC clone 24810 was used in all experiments as the genomic DNA template. Sequencing starting at flanking BAC vector sites established the presence of the entire Scn5a genomic DNA fragment with 87 kb of 5Ј-and 20 kb of 3Ј-flanking sequences. The Scn5a gene itself was ϳ100 kb in length, including the 5Ј-and 3Ј-UTRs.
Identification of Three 5Ј-and Two 3Ј-UTR Splice Variants-In both humans and rats, Northern analysis shows that the SCN5A mRNA size is ϳ 8.5 kb (19 -21) . The first mouse Scn5a cDNA for this channel (GenBank TM accession number AJ271477) was 6.5 kb, with a 5Ј-end extending only to 50 bp upstream of the ATG codon and a 348-bp 3Ј-UTR, which is considerably shorter than published human and rat UTRs. Therefore, we undertook to evaluate whether the previously reported mouse UTR sequences represented the full extent of the mouse clone. The RACE procedure was employed to the 5Ј-and 3Ј-mRNA ends upstream of the start codon and downstream of the stop codon, respectively. PCR amplification of cDNA yielded several distinct bands on gel electrophoresis. Subsequent nested PCR amplification gave two bands (500 and 200 bp) in fetal heart RNA and one band (380 bp) in adult heart RNA (Fig. 1) . Sequences of these bands showed that the 500-and 380-bp bands were Scn5a gene-specific. A comparison between the 5Ј-RACE-PCR products and genomic sequences showed that there were two different exon 1 isoforms; one was 368 bp and located 15.3 kb upstream of exon 2. Another isoform was 269 or 197 bp and was separated by only 610 bp from exon 2. From the RACE procedure, we were unable to obtain the exon 1 isoform reported previously (22) , suggesting that a total of three exon 1 splice variants existed. This possibility was confirmed by PCR using the primers HRE1F and mE2R (Table  I) , producing a 97-bp exon 1 isoform located 454 bp upstream of the 368-bp exon. We named these untranslated cDNA fragments, exon 1A (97 bp), exon 1B (368 bp), and exon 1C (269 or 197 bp), respectively. Exon 1A, identified by primer extension and RNase protection, has been reported previously in human and rat (9, 18) with a length ranging from 97 to 176 bp (10, 19) .
Of the sequences containing exon 1A reported in the GenBank TM , no full-length clones were obtained using RACE methods. There are several possible explanations for the failure of 5Ј-RACE analysis to identify this exon 1 variant. One possibility is that the high GC content and low CpG frequency within 3 kb of the 5Ј-flanking region generated a complex secondary structure that impeded polymerase activity. We observed several short GC-rich (Ͼ60%) stretches upstream of each of the Scn5a exon 1 sequences, but the frequency of CpG was unexpectedly low. Nevertheless, RACE tends to be insensitive to high GC content. Another possibility is that the full-length mRNA is easily truncated, and in this case, the commercial kits such as the one we used would be unable to amplify the full sequence. This idea is consistent with the finding of multiple TSSs by the previously mentioned alternative methods (23) . It is possible that these represent various truncations rather than unique TSSs.
Analysis of the 3Ј-UTR showed evidence of splice variations in fetal and adult heart. By RACE-PCR using GSP3Ј-and oligo(dT) primers (Table I) , we identified two alternative 3Ј-UTRs (Fig. 1C) . Comparison of genomic and cDNA sequences showed that the 3Ј-UTRs had two different poly(A) splicing variants. One was short, 347 bp after the stop codon, and was consistent with the published mouse Scn5a cDNA (GenBank TM accession number AJ271477). Additionally, there was a second, long variant of 2176 bp, which corresponded to the human SCN5A cDNA 5Ј-UTR (GenBank TM accession number NM_198056). A summary of the findings is presented in Fig. 2 .
5Ј-and 3Ј-UTR Splice Variants
Are Developmentally Regulated-Na v 1.5 expression is developmentally regulated (11, 24) . Splice variants in the 5Ј-UTR are known to regulate expression during development and formation of tissues (25) (26) (27) . Therefore, we investigated whether our identified, novel 5Ј-UTR isoforms varied during development, a prerequisite for their contribution to the observed regulation of expression. We employed real time PCR to analyze the relative abundance of the Scn5a mRNA splice variants. Real time PCR results indicated that the abundance of each exon 1 isoform increased 7.8 Ϯ 1.7-fold (n ϭ 8), 6.0 Ϯ 1.0-fold (n ϭ 8), and 20.6 Ϯ 3.7-fold (n ϭ 8) (Fig. 3A) in the adult relative to the respective fetal heart abundance. Using exon 1A as a standard, exon 1A, 1B, and 1C mRNA abundance was 1.0 Ϯ 0.1-fold (n ϭ 8), 1.3 Ϯ 0.2-fold (n ϭ 8), and 0.5 Ϯ 0.1-fold (n ϭ 8) in fetal heart and 1.0 Ϯ 0.2-fold (n ϭ 8), 1.0 Ϯ 0.2-fold (n ϭ 8), and 1.2 Ϯ 0.2-fold (n ϭ 8) in adult heart, respectively (Fig. 3B) . Exon 1C was the least abundant in fetal heart and increased the most with development. In adult heart, the relative mRNA abundance of the isoforms was statistically equivalent.
The 3Ј-UTR length was also developmentally regulated. As shown in Fig. 1C , both the short and long forms of the 3Ј-UTR were present in fetal and adult heart. Analyzed by densitometry relative to ␤-actin, there was no statistical change in the amount of the long form, but the abundance of the short form   FIG. 1. PCR results for detecting the TSS, exon 1 variants, and 3 -UTR isoforms of the mouse cardiac Scn5a gene. Total RNA from fetal and adult heart was used to determinate the TSS and exon 1 isoforms with Scn5a-specific primers. A, RACE-PCR analysis showing the fetal heart lane (FH) demonstrates two bands, only the larger of which contained cardiac-specific Na ϩ channel sequences. This band corresponds to exon 1B. A second splice variant is noted in adult heart (AH). This corresponds to exon 1C. Both isoforms were novel compared with the previously reported 5Ј-UTR. B, PCR confirms the presence of 1B and 1C in fetal and adult heart, respectively, and demonstrates at each developmental stage, a third exon, exon 1A. The presence of three unique exon 1 isoforms was confirmed by sequencing. C, RACE-PCR shows two 3Ј-UTR isoforms present in Scn5a mRNA of fetal and adult mouse heart. M, DNA step ladder lanes. was reduced in adult heart by 62% (p Ͻ 0.01) compared with that in fetal heart (Fig. 3C) . Functional Analysis of the Scn5a Promoter Region-Na v 1.5 shows tissue-specific restriction predominately limited to cardiac and skeletal muscle. Expression is relatively low in skeletal muscle when compared with Na v 1.4 encoded by Scn4a. To help understand the origin of this tissue specificity, we constructed plasmids containing different 5Ј-regions of the Scn5a gene inserted upstream of a luciferase reporter gene. Because of its size, we divided the 5Ј-region and analyzed reporter constructs based upon two regions encompassing the entire putative promoter (Fig. 4, A and B) . The luciferase activities of these constructs were compared after transient transfection into cardiac (H9c2) and skeletal muscle (C2C12) cell lines. In all experiments, the transfection efficiency was normalized by cotransfecting with the plasmid pRSV-␤-gal, which contained the ␤-galactosidase gene under control of the Rous sarcoma virus promoter. Successive deletions in the promoter region revealed that exons 1A and 1C had associated elements that conferred increased activity in the heart cell line. Elements associated with exon 1B but not 1C enhanced expression in the skeletal muscle. Fragment Pb0.8 (Ϫ855 to Ϫ24), containing exon 1C, showed the strongest promoter activity in the H9c2 cells (129.3 Ϯ 6.0 relative light units). Core promoter sequences are shown in Fig. 5 . DISCUSSION Na ϩ current is critical for nerve, heart, and skeletal muscle function. In the case of heart, the SCN5A gene encodes the vast majority of Na ϩ current. The encoded Na v 1.5 channel is the target of many anti-arrhythmic drugs, and mutations in the channel coding sequence yield sudden death syndromes. In mice and humans, Na v 1.5 is developmentally regulated, expressed predominately in cardiac and skeletal muscle, and varies during disease (15, 16, 28, 29) . Despite its physiological importance, little is known about the transcriptional or translational regulation of this gene. Here, we report that the mouse Scn5a gene encodes for three mutually exclusive untranslated exon 1 variants and two different 3Ј-untranslated regions. This allows for the possibility of six different Scn5a mRNAs (Fig.  2B) . Because 3Ј-and 5Ј-UTRs are important in controlling mRNA stability, cellular and subcellular localization, and translation activation or repression (30, 31) , it is likely that these sequence variations can contribute to the variable ex- . Splicing patterns for each of the three exon 1 isoforms are identified at the bottom. B, predicted mouse Scn5a cDNA isoforms. With three 5Ј-UTR and two 3Ј-UTR variants, there are a total six possible cDNA isoforms: cDNAAS (exon 1A and the short 3Ј-UTR), cDNABS (exon 1B and the short 3Ј-UTR), cDNACS (exon 1C and the short 3Ј-UTR), cDNAAL (exon 1A and the long 3Ј-UTR), cDNABL (exon 1B and the long 3Ј-UTR), and cDNACL (exon 1C and the long 3Ј-UTR). Because RACE-PCR did not identify the TSS, the exact length of transcripts containing exon 1A cannot be calculated.
pression of Na v 1.5. Consistent with playing a regulatory role in Na ϩ current, the splice variants differ in relative abundance during development, with a prominent up-regulation of exon 1C and down-regulation of the short 3Ј-UTR mRNA forms in an adult compared with a fetal heart.
The long Scn5a 5Ј-flanking sequence has the features of FIG. 3 . UTR isoform abundance as a function of development. A and B indicate the relative -fold change of the three 5Ј-UTR variants normalized to their respective fetal mRNA abundance (A) and to the exon 1A abundance at each developmental stage (B). Exon 1C was the least abundant in fetal heart (FH) and increased the most with development. In fetal heart, exon 1C was least abundant (*, p Ͻ 0.01 when compared with exon 1A). In adult heart (AH), the relative mRNA abundance of the isoforms was statistically equivalent. C shows semiquantitative analysis of the abundance of the 3Ј-UTR isoform transcripts. Analyzed by densitometry, there was no statistical change in the amount of the long form (3Ј-UTR L), but the abundance of the short form (3Ј-UTR S) was reduced in adult heart by 62% (ૺ, p Ͻ 0.01, n ϭ 3 for each bar) compared with that in fetal heart. ␤-Actin was used as a reference in all cases.
FIG. 4.
Functional analysis of mouse Scn5a promoter construct activities in H9c2 heart and C2C12 skeletal muscle cell lines. A shows mouse cardiac Na ϩ channel ␣-subunit (Scn5a) promoter A fragment-reporter constructs. The top line shows the structural organization of the 5Ј-end of the Scn5a promoter (3.2 kb). Note the presence of exons 1A and 1B. B shows Scn5a promoter B fragment-reporter constructs. The top line shows the structural organization of this region of the Scn5a promoter (3.0 kb). Note the presence of exon 1C and part of exon 2, which contains the translation start site. Labels on the right indicate promoter-luciferase constructs representing genomic DNA fragments corresponding to the region of the Scn5a promoter shown to the left. Nucleotide numbering starts with ϩ1 corresponding to the protein translation start site. C shows the functional analysis of promoter activities. Scn5a promoter-luciferase constructs were transiently transfected into the cardiomyocytes cell line (H9c2) and the skeletal muscle cell line (C2C12). Luciferase activity in each well was normalized to ␤-galactosidase activity to correct for transfection efficiency. pGL3-control (SV40 promoter and enhancer-plus) and pGL3-basic (promoterless) were used in all transfection experiments as positive and negative controls. Data are presented as mean Ϯ S.E. based on at least six separate transfection experiments for each cell line.
TATA-less and TATA-plus promoters and has multiple sites for initiation of transcription, suggesting the possibility of complex transcriptional and translational regulation. The long Scn5a 5Ј-UTR is similar to other growth factors, proto-oncogenes, transfactors, and ion channel genes, which also show long 5Ј-UTRs (32). These 5Ј-UTRs often show multiple transcription start sites, as does the Scn5a gene (19) . We identified two TSSs associated with exon 1C (Fig. 4B) . Previously, three TSSs have been identified in the human SCN5A gene in sequences preceding our exon 1A (10) . Nine potential TSSs have been identified in rat muscle (19) . Adding the possibility of more complex regulation, the total identified promoter region contained consensus binding sites for several transcription factors that may be functionally important, including Sp-1, GATA-1, AML-1a, Lyf-1, c-Myc, v-Myc, and Est-1.
The H9c2 heart and C2C12 skeletal muscle cell lines allowed us to investigate the tissue-specific effects of potential regulatory sequences on reporter expression. The Pa-PSI fragment enhanced reporter expression in both cardiac and skeletal muscle. This region had been shown previously to enhance rSkM2 expression in the L6 skeletal muscle cell line (19) . Our results with the fragments Pa-ASI and Pa-ASII were similar to those seen with the analogous human SCN5A promoter region expressed in rat neonatal cardiac myocytes (10, 20) . The promoter regions associated with exons 1A and 1C conferred increased expression of the reporter in a cardiac cell line. Sequence analysis showed GATA-4, Nkx2.5, CCAC, and MyoD transcription factor binding sites preceding exons 1A and 1C, consistent with transcription of these variants in cardiac development (33) . There were C-ets-1 transcription factor binding sites in the repressor segments preceding the cardiac-specific enhancer elements (27) . Our results suggest that exon 1B and its preceding segments may be most important for skeletal muscle expression of Scn5a. Because cell lines were used, these results may differ in native cells but suggest the possibility of complex transcriptional regulation with two cardiac-specific promoter regions.
In conclusion, our results suggest the possibility of complex transcriptional and translational regulation of the cardiac sodium channel. The Scn5a promoter region is large and complex including repressor elements, tissue-specific promoter elements, and three untranslated exon 1 variants. The abundance of alternatively spliced exon 1 and 3Ј-UTR mRNAs varied with development. Whereas these studies were conducted in mice, sequence comparison and preliminary data indicate that the human SCN5A gene is organized in an analogous way. It is likely that complex genetic regulation contributes to alteration of the Na v 1.5 current during development and disease and may be a fruitful area of exploration in inherited arrhythmic syndromes that cannot be explained by coding region mutations.
